REGIONAL ANESTHESIA IN ADULTS
From Regional Anesthesia 2008, sponsored by Virginia Mason Medical Center, Seattle, WA
Educational Objectives
The goals of this program are to increase knowledge of regional techniques for orthopedic surgery and effectively use
upper-extremity blocks while preventing associated complications. After hearing and assimilating this program, the
clinician will be better able to:
 | 1. Discuss hypotensive epidural anesthesia for total hip replacement.
|
 | 2. Make informed decisions about the use of mepivacaine for spinal anesthesia.
|
 | 3. Apply knowledge of anesthesia and analgesia for total knee replacement.
|
 | 4. Review evidence to support the use of upper-extremity anesthetic blocks.
|
 | 5. Analyze techniques to ensure the success of upper-extremity anesthetic blocks, review the pharmacology of
the brachial plexus, and list possible complications associated with peripheral nerve blockade.
|
Faculty Disclosure
In adherence to ACCME Standards for Commercial Support, Audio-Digest requires all faculty and members of the
planning committee to disclose relevant financial relationships within the past 12 months that might create any personal
conflicts of interest. Any identified conflicts were resolved to ensure that this educational activity promotes
quality in health care and not a proprietary business or commercial interest. For this program, the faculty and planning
committee reported nothing to disclose.
Acknowledgements
Drs. Liguori and Neal spoke in Seattle, WA, at Sleepless in Seattle: East Meets West 2, Regional Anesthesia 2008, held
August 8-10, 2008, and sponsored by Virginia Mason Medical Center, Seattle, WA. The Audio-Digest Foundation
thanks the speakers and Virginia Mason Medical Center for their cooperation in the production of this program.
Regional Techniques for Orthopedic Surgery
Gregory A. Liguori, MD, Clinical Associate Professor of Anesthesiology, Weill Medical College of Cornell University,
and Director, Department of Anesthesiology, and Anesthesiologist-in-Chief, Hospital for Special Surgery, New York, NY
| Hypotensive epidural anesthesia for total hip replacement: total hip replacement associated with substantial
blood loss (≤1 L) and high rates of deep venous thrombosis (DVT) and pulmonary embolism (PE); neuraxial anesthesia
traditionally associated with lower rates of DVT and PE, possibly due to inhibition of inflammatory mediators
or enhanced or selective blood flow in lower extremities; hypotensive anesthesia associated with less blood loss (related
to blood pressure [BP], not cardiac output); technique involves extensive sympathetic block via epidural or
combined spinal-epidural (CSE), low-dose epinephrine infusion, and placement of radial artery lines (to monitor
BP)
|
 | Extensive sympathetic block: suppresses levels of endogenous catecholamines, epinephrine, and norepinephrine;
blocks cardiac accelerator fibers (T1 through T4); leads to decreases in heart rate (HR), central venous pressure
(CVP), BP, cardiac output, and stroke volume; addition of epinephrine infusion controls circulation; Sharrock
(1992) compared phenylephrine and epinephrine; found cardiac index maintained with epinephrine, but dropped
significantly with phenylephrine; starting low-dose epinephrine alone results in increases in HR and CVP, mild
decrease in BP, and increase in cardiac output and stroke volume; combination of extensive epidural block, epinephrine
infusion at low rate, and close monitoring results in stable HR and CVP, significantly decreased BP, stable
cardiac output, and stable stroke volume
|
 | Efficacy: significantly less blood loss and fewer blood transfusions; bone-cement interface improved in short term;
significantly lower rates of DVT, PE, and mortality
|
 | Safety: no increased incidence of stroke, myocardial infarction (MI), or acute renal failure; study looked at total hip
replacement under hypotensive epidural anesthesia in patients >70 yr of age with either cardiac disease, hypertension,
or diabetes; low BP technique compared with normotensive technique; no differences in cognitive outcomes
(at 1 wk and 4 mo) after surgery or in medical complications between groups
|
 | Contraindications: significant carotid stenosis; renal insufficiency; severe aortic stenosis (AS); idiopathic hypertrophic
subaortic stenosis (IHSS)
|
| Use of mepivacaine as spinal anesthetic: mepivacaine, isobaric lidocaine, isobaric bupivacaine, 2-chloroprocaine,
and narcotics (eg, fentanyl, hydromorphone) not approved for spinal anesthesia
|
 | Safety and toxicity of local anesthetics (animal studies): Japanese study (Kasaba et al, 2003) in snails found mepivacaine
had least adverse effects on growth cones; another Japanese study evaluated growth cones in chicks and found mepivacaine
safest drug and lidocaine most toxic; study (Takenami et al, 2004) in rats concluded histologic damage and neurofunctional
impairment significantly more severe with highly concentrated lidocaine than with mepivacaine or
prilocaine; Gentili study (1980) looked at microscopic evaluation of nerve injury in rats; with intrafascicular injection,
most damage occurred with tetracaine, procaine, and lidocaine; least damage with mepivacaine and bupivacaine
|
 | Speakers retrospective evaluation: looked at outcomes after mepivacaine spinal anesthetic over 3 yr; mean dose ≈52 mg
(range, 15-75 mg); 24 cases of new postoperative neurologic findings; 10 cases involved mepivacaine (7 peripheral
neuropathies; 1 case of spinal cord needle trauma; 1 related to epidural infusion; 1 unrecognized spinal stenosis)
|
 | Efficacy: onset of action, 2 to 3 min; dose-dependent duration of action; high success rates; speakers study of dose-
response methodology for knee arthroscopy found 45 and 60 mg mepivacaine adequate for most patients; duration
of action ≈2 hr for lower extremity blocks and 90 to 120 min for motor blocks; higher doses of isobaric mepivacaine
(60 and 80 mg) for anterior cruciate ligament (ACL) reconstruction showed dose-dependent duration
of action on sensory and motor function
|
 | Side effects: transient neurologic symptoms (TNS)in speakers prospective study comparing mepivacaine to
lidocaine, mepivacaine shown to have lower incidence of TNS; later studies showed no difference between
lidocaine and mepivacaine in incidence of TNS; subsequent studies found 0% to 30% incidence of TNS with mepivacaine;
YaDeau (2005) performed prospective study and found 6% incidence of TNS with mepivacaine spinal
|
| Anesthesia and analgesia for total knee replacement: anesthesiaspinal; epidural; general; CSE; peripheral
nerve blocks (PNBs); analgesiapatient-controlled epidural analgesia (PCEA); intravenous (IV) patient-controlled
analgesia (PCA); femoral nerve block; sciatic nerve block; various combinations of catheters and blocks;
considerationspatient; surgeon; anesthesia provider; safety and efficacy; thromboprophylaxis; rehabilitation
schedule
|
 | Hospital for Special Surgery (HSS): generally use neuraxial regional anesthesia; surgeons use warfarin or aspirin
for thromboprophylaxis; patient out of bed on morning of first postoperative day
|
 | Capdevila study (2005): continuous epidural infusion and continuous femoral nerve block associated with less pain
and better rehabilitation than IV PCA; complications higher with epidural infusions than with continuous femoral
nerve block; however, anesthetic in epidural infusion was 1% concentrated lidocaine (causes dysesthesias and
arterial hypotension)
|
 | Other studies: Barrington (2005) compared continuous femoral nerve block to continuous epidural; both provided
equivalent pain relief at rest and in motion; narcotic use higher with continuous femoral nerve block, but more nausea
in epidural group; postoperative range of motion and rehabilitation similar; Salinas (2006) compared single-shot
femoral nerve block to continuous femoral nerve block; both placed after resolution of spinal anesthesia; after day
1, continuous femoral nerve block associated with lower pain scores than single shot; hospital length-of-stay and rehabilitation
milestones comparable
|
 | Techniques at HSS: PCEA plus single-shot femoral nerve block using low concentration local anesthetic; YaDeau
found femoral nerve block associated with improved flexion and pain scores through postoperative day 2
|
Upper-Extremity Blocks: Making Them Work and Preventing Complications
Joseph M. Neal, MD, Clinical Professor of Anesthesiology, University of Washington School of Medicine, and Staff Anesthesiologist,
Virginia Mason Medical Center, Seattle
| Supportive evidence: interscalene, infraclavicular, and axillary blocks (compared to fast-track general anesthesia)
provide better analgesia, decreased opioid side effects, fewer instances of delayed discharge due to nausea and
vomiting, and fewer unplanned admissions; once block has worn off, no discernible difference between regional
technique and general anesthetic technique; extending block with perineural catheter can be done quickly (and surgeon
can bill for procedure), but less effective than single-shot or continuous analgesia, and recent evidence suggests
perineural catheter may do harm (particularly with subacromial infusions around fresh joints and cartilage);
studies from orthopedic literature indicate continuous subacromial and intra-articular infusions as effective as suprascapular
nerve block or interscalene block; however, studies usually unblinded and nonrandomized
|
| Nerve localization: no evidence that choice of technique influences efficacy or safety
|
| Ultrasonography (US): most studies suggest US-guided block at least as fast as nerve stimulation-guided block;
however, studies fail to include time required to set up, perform preliminary scan, and place sheath over probe; onset
of anesthesia varies; placing local anesthetic near nerve increases concentration gradient, reducing onset time by
2 to 4 min; block quality also variable; no studies proving US safer than other techniques (case reports of complications
increasing); studies found no major differences in success rates whether peripheral nerve stimulation (PNS)-
guided or US-guided axillary blocks used
|
| Interscalene or supraclavicular block: transarterial, paresthesia, or PNS-type techniques; at origins of brachial
plexus, single injection effective; where brachial plexus divides into cords and terminal nerves, 2 to 3 stimulations or
injections better than single stimulation; 4 stimulations slightly better but require more time; ideal axillary technique
includes injection near radial, musculocutaneous, and median nerves (less important to inject near ulnar nerve)
|
| Infraclavicular block: also better with dual stimulation than single stimulation, both with US and PNS; one injection
at posterior cord; studies consistently show infraclavicular block superior to axillary block for surgical anesthesia
|
| Continuous perineural catheter: no evidence that continuous injection techniques increase complications (eg, nerve
injury, intravascular injection, infection); shown to promote earlier discharge; may improve rehabilitation; more labor-
intensive than single-shot block; more difficult (especially without aid of US) to place catheter around brachial plexus
than around femoral nerve; patients prefer ambulatory discharge if designated provider available 24 hr/day by telephone
|
| Selective nerve blocks: either 1) not part of brachial plexus (but involved with upper-extremity surgery), or 2) part
of brachial plexus but, because of branching pattern or ineffective spread of local anesthetic, can be missed with
regional anesthetic or require supplement
|
 | Suprascapular nerve block: primarily sensory nerve; isolated block reduces pain in shoulder arthroscopic procedures
under general anesthesia; technique involves placing needle toward scapular spine near suprascapular
notch, and blindly injecting 5 to 10 mL of local anesthetic; decreases nausea and vomiting and rate of unplanned
admission; useful in recovery, for patients in pain despite seemingly effective interscalene block
|
 | Antebrachial cutaneous block: primary anesthesia or rescue anesthesia for volar forearms; subcutaneous infiltration
in lower part of upper arm blocks medial antebrachial nerve; lateral antebrachial nerve blocked at cutaneous terminus
of musculocutaneous nerve in lateral forearm; does not require placing needle toward peripheral nerve that
may be partially blocked and perhaps more prone to injury
|
 | Supraclavicular nerve: terminal branches from superficial cervical plexus innervate cape of shoulder; blocked by interscalene
approach, due to proximal spread of local anesthetic; more distal block likely to miss supraclavicular
nerve; superficial cervical plexus block often beneficial
|
| Pharmacology of brachial plexus: local anesthetics and adjuvants often affect central and peripheral nerves differently
(eg, relationship between dose and duration of action); selection of local anesthetic for brachial plexus
block ultimately determined by desired length of block (eg, short-acting, 2-chloroprocaine; intermediate-acting
[4-6 hr], lidocaine or mepivacaine; long-acting, bupivacaine or ropivacaine); bupivacaine and ropivacaine not
equipotent (0.75% ropivacaine required to obtain same block characteristics as 0.5% bupivacaine); for infusion,
0.2% to 0.15% ropivacaine comparable to 0.15% to 0.125% bupivacaine; some evidence of greater preservation
of motor function with ropivacaine than with bupivacaine; PNB often may be overdosed, but from practical
standpoint, nothing wrong with overdosing PNBs as long as you dont have an accident (eg, nerve damage, intravascular
injection); ultralongacting local anesthetics not currently available but highly effective
|
 | Adjuvants: mostly used with intermediate- and long-acting drugs; however, common adjuvants (eg, epinephrine,
clonidine) have little effect on long-acting local anesthetics (cleared at same time or before long-acting local anesthetic);
epinephrineprolongs blockade; acts as intravascular marker; decreases rapid uptake of local anesthetics;
increases intensity of block; negative effects include tachycardia and decreased peripheral nerve blood
flow (reducing concentration to 2.5 µg/mL eliminates tachycardia and decreases duration by only 10-15 min);
clonidinein relatively small doses, prolongs anesthesia and analgesia by ≈50%; if total dose <150 µg, patient
typically does not experience sedation or hypotension; expensive; no better than epinephrine as adjuvant; not recommended
for infusion (does not prolong effect or decrease breakthrough pain; increases motor block);
buprenorphine0.3-mg dose increases duration of block
|
 | Alkalinization: sodium bicarbonate added to lidocaine epidural increases speed of onset by 5 to 10 min; however, addition
of sodium bicarbonate to lidocaine or mepivacaine PNB does not decrease onset time; animal studies show decreased
duration and intensity of block; addition of epinephrine results in <1-min increase in speed of onset;
significant effect only when added to commercially prepared lidocaine with epinephrine (preparations highly acidic)
|
| Complications: higher incidence of death and cardiac arrest with neuraxial block, compared to PNB, but risk for seizure
5 times more likely with PNB than with epidural block; PNB damages nerves less often than does spinal anesthesia;
hemidiaphragmatic paresisif patient cannot withstand 25% to 30% reduction in pulmonary function, regional
anesthesia above clavicle contraindicated; pneumothoraxdecreased incidence with modern approaches to placing
supraclavicular block (eg, plumb-bob, subclavian perivascular) using US; unintended destinationbe vigilant and aggressive
in resuscitation; nerve injury80% to 85% of perioperative nerve injury not caused by anesthesia (focus on
surgical and patient-related causes); causes include mechanical trauma, ischemic injury, and chemical injury; no evidence
that sharp needle better or worse than blunt needle; if perineural barrier broken, normal clinical concentrations
can become toxic (exacerbated by epinephrine)
|
Suggested Reading
Capdevila X et al: Continuous peripheral nerve blocks in hospital wards after orthopedic surgery: a multicenter prospective
analysis of the quality of postoperative analgesia and complications in 1,416 patients. Anesthesiology 103:1035, 2005; Gentili F
et al: Nerve injection injury with local anesthetic agents: a light and electron microscopic, fluorescent microscopic, and horseradish
peroxidase study. Neurosurgery 6:263, 1980; Kasaba T et al: Procaine and mepivacaine have less toxicity in vitro than
other clinically used local anesthetics. Anesth Analg 97:85, 2003; Liguori GA et al: Transient neurologic symptoms after spinal
anesthesia with mepivacaine and lidocaine. Anesthesiology 88:619, 1998; Neal JM et al: Brachial plexus anesthesia: essentials
of our current understanding. Reg Anesth Pain Med 27:402, 2002; Salazar F et al: Transient neurologic symptoms after
spinal anaesthesia using isobaric 2% mepivacaine and isobaric 2% lidocaine. Acta Anaesthesiol Scand 45:240, 2001; Salinas
FV et al: The effect of single-injection femoral nerve block versus continuous femoral nerve block after total knee arthroplasty
on hospital length of stay and long-term functional recovery within an established clinical pathway. Anesth Analg 102:1234,
2006; Sharrock NE et al: The hemodynamic and fibrinolytic response to low dose epinephrine and phenylephrine infusions
during total hip replacement under epidural anesthesia. Thromb Haemost 68:436, 1992; Takenami T et al: Intrathecal mepivacaine
and prilocaine are less neurotoxic than lidocaine in a rat intrathecal model. Reg Anesth Pain Med 29:446, 2004; Terai T
et al: A double-blind comparison of lidocaine and mepivacaine during epidural anaesthesia. Acta Anaesthesiol Scand 37:607,
1993; Williams-Russo P et al: Randomized trial of hypotensive epidural anesthesia in older adults. Anesthesiology 91:926,
1999; YaDeau JT et al: The effects of femoral nerve blockade in conjunction with epidural analgesia after total knee arthroplasty.
Anesth Analg 101:891, 2005; YaDeau JT et al: The incidence of transient neurologic symptoms after spinal anesthesia
with mepivacaine. Anesth Analg 101:661, 2005.
|